Report Id: SNS/HC/2625 | July 2022 | Region: Global | 135 Pages
Report Scope & Overview:
The Endoprosthesis Market Size was valued at USD 13.60 billion in 2022 and is expected to reach USD 33.69 billion by 2030, and grow at a CAGR of 12% over the forecast period 2023-2030.
Endoprosthesis is a treatment that involves the use of an implant to replace a joint in the body that has lost its ability to function due to injury or illness. Common indications for the use of an endoprosthesis include degenerative joint disease, fractures, and malignancies. The increasing prevalence of osteoarthritis among the older population, technological improvements in endoprosthesis devices permitting efficient treatment, and increased population awareness are driving the worldwide endoprosthesis market. However, the undesirable effects and high costs associated with endoprosthesis are anticipated to limit market expansion.
Endoprosthesis technological improvements enable better treatment, and increased awareness for prosthetics in orthopaedic injuries are fueling the growth of the end prosthesis market.
The prevalence of knee and hip osteoarthritis is rapidly growing as the ageing population grows.
Another important cause is the rising prevalence of orthopaedic ailments and peripheral vascular diseases.
In emerging countries, there is a lack of healthcare infrastructure and affordability.
Rising awareness of modern technologies among patients and healthcare professionals would give a long-term potential for the endoprosthesis industry to flourish.
An increase in the number of product launches, mergers and acquisitions, and expansion
The biggest market barriers include limited reimbursement policies in low and middle income countries and inadequate performance of indigenous products.
The increasing severity of diseases resulted in a substantial market expansion during the forecasted period.
IMPACT OF COVID-19:
COVID-19 has not only harmed humanity, but it has also caused economic destruction around the world. This pandemic is believed to have had much more destructive repercussions on the global economy than the 2008-2009 financial crisis. It has had a negative impact on the demand and supply chain, significantly harming global trade. The supply chain is critical for meeting client requests. As a result of COVID-19, some nations imposed import and export restrictions, affecting the supply of raw materials necessary in the endoprosthesis market. However, when the lockdown is lifted in many countries and rules are relaxed, a steady rebound in the supply-demand for endoprosthesis can be envisaged in the future years.
Furthermore, beginning in mid-March 2020, physicians were directed to undertake only needed surgical procedures in order to assist combat the COVID-19 epidemic and preserve crucial health care resources. The majority of arthroplasty surgeries, including endoprosthesis treatments, do not qualify as necessary surgery. This resulted in a considerable number of procedures being cancelled around the world. For example, according to a report published in July 2020 by the Department of Orthopedics and Rehabilitation at the University of Iowa, approximately 30,000 primary and 3,000 revision hip and knee arthroplasty procedures would be cancelled each week while COVID-19 restrictions on non-essential surgery are in place.
The enormous number of procedures cancelled as a result of COVID-19 results in significant financial losses for health care facilities and may have a significant impact on patients.
The market is divided into five product categories: knee, hip, shoulder, elbow, finger/hand, and ankle/foot. In 2021, the knee segment dominated the market, as it is the largest and fastest-growing segment, with a CAGR of 12.73 percent. During the projection period, the rapidly ageing population and the worrisome trend of obesity will lead to an increase in demand for knee replacement surgery.
Primary knee replacement, partial knee replacement, custom-made replacements, revision knee replacement, and tumour are the several types of knee replacement. According to a recent study, the pooled global prevalence of knee osteoarthritis was 16.0 percent in people aged 15 and up and 22.9 percent in people aged 40 and above.
The worldwide endoprosthesis market is segmented by hip type, including main hip replacement, partial hip replacement, revision hip replacement, tumour, and custom-made partial pelvic replacements. Factors such as increased patient awareness about the use of prostheses in orthopaedic injuries and the growth in the prevalence of hip osteoarthritis among the senior population are driving the worldwide endoprosthesis market for hip replacement. Although more expensive, cementless prostheses have become the most popular type of prosthesis used for total hip replacement in various countries, including the United Kingdom, Italy, Australia, Canada, and the United States.
The worldwide endoprosthesis market is divided into four segments: main shoulder replacement, revision shoulder replacements, tumour, and custom-made replacements. The healthy shoulder joint has the greatest range of motion of any joint in the human body. It supports rotations and movements in several directions. Humans cannot successfully use their arms and hands without it.
The worldwide endoprosthesis market is divided into whole elbow replacement, radial head replacement, tumour, and custom-made replacements depending on elbow. Elbow arthroplasty involves the use of prosthesis that replace the distal humerus and proximal ulna's normal surface anatomy. Elbow replacement is less prevalent than knee or hip replacement. It is, however, equally effective in reducing joint discomfort and returning patients to their normal activities.
Johnson & JohnsonServices, Inc., CorinLtd, MedactaInternational SA, BraunMelsungenAG, Zimmer Biomet HoldingsInc., Stryker, Smith & Nephew, Exactech, Inc., MicroPortOrthopedics,Inc.
Revision Hip Replacement
Revision Shoulder Replacement
Radial Head Replacement
Revision Knee Replacement
In 2021, North America had the greatest market share. The endoprosthesis market in North America is being driven by the region's increased use of technically advanced healthcare items as well as an increase in arthritis instances.
South America has shown significant growth in the endoprosthesis market, with a 14.6 percent market share in 2021. Endoprosthesis procedures are performed in a variety of medical settings throughout South America, including government-controlled laboratories. Patients who are financially independent frequently choose private laboratory care. Brazil is one of the leading countries in the South American endoprosthesis market, with the greatest market share.
Asia-Pacific is expected to develop at the fastest rate during the projection period of 2021 to 2028, with a CAGR of 12.78 percent. This is due to factors such as the region's growing older population, an increase in the incidence of osteoarthritis, and increased spending on healthcare infrastructure. Every day, more people become aware of numerous ailments and the importance of receiving high-quality care. In China, around 50,000 knee and hip arthroplasties are performed each year. This figure is likely to rise significantly in the coming years due to an increase in the incidence of orthopaedic injuries and orthopaedic ailments among the country's elderly population.
Europe has a 24.59 percent market share in 2021 and is predicted to grow at a 12.41 percent CAGR during the forecast period. The rise in the senior population, higher prevalence of joint problems, and enhanced healthcare infrastructure in the region are all contributing to market expansion.
The Middle East and Africa endoprosthesis market is expanding due to considerable improvements in healthcare infrastructure and the growing presence of important players in the area.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 13.60 Billion|
|Market Size by 2030||US$ 33.69 Billion|
|CAGR||CAGR of 12% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• by Hip (Primary, Partial, Revision Hip Replacement, Tumor, Custom Made)
• by Shoulder (Primary, Revision Shoulder Replacement, Tumor, Custom Made)
• by Elbow (Total Elbow, Radial Head Replacement, Tumor, Custom Made)
• by Product (Knee, Hip, Shoulder, Elbow, Finger/Hand, Ankle/Foot)
• by Knee (Primary, Partial, Revision Knee Replacement, Tumor, Custom Made)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Johnson & JohnsonServices, Inc., CorinLtd, MedactaInternational SA, BraunMelsungenAG, Zimmer Biomet HoldingsInc., Stryker, Smith & Nephew, Exactech, Inc., MicroPortOrthopedics,Inc.|
|Key Drivers||• The prevalence of knee and hip osteoarthritis is rapidly growing as the ageing population grows.|
|RESTRAINTS||• In emerging countries, there is a lack of healthcare infrastructure and affordability.|
Frequently Asked Questions (FAQ) :
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8.Endoprosthesis Market, by Hip
8.3 Revision Hip Replacement
8.5 Custom Made
9.Endoprosthesis Market, by Shoulder
9.2 Revision Shoulder Replacement
9.4 Custom Made
10.Endoprosthesis Market, by Elbow
10.1 Total Elbow
10.2 Radial Head Replacement
10.4 Custom Made
11.Endoprosthesis Market, by Product
12.Endoprosthesis Market, by Knee
12.3 Revision Knee Replacement
12.5 Custom Made
13. Regional Analysis
13.2 North America
13.3.6 The Netherlands
13.3.7 Rest of Europe
13.4.2 South Korea
13.4.6 Rest of Asia-Pacific
13.5 The Middle East & Africa
13.5.3 South Africa
13.6 Latin America
13.6.3 Rest of Latin America
14.1 Johnson & JohnsonServices, Inc.
14.1.2 Products/ Services Offered
14.1.3 SWOT Analysis
14.1.4 The SNS view
14.3 MedactaInternational SA
14.5 Zimmer Biomet HoldingsInc.
14.7 Smith & Nephew
14.8 Exactech, Inc.
15. Competitive Landscape
15.1 Competitive Benchmarking
15.2 Market Share analysis
15.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.